Salute e Benessere

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 6 February 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
06/02/2024

The Future of Brain Monitoring: Market Size poised to Cross US$ 12.5 Billion by…

Request Exclusive Sample Report: Brain Monitoring Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18931 Request Exclusive Sample Report: Brain Monitoring Industry Strategic Insights,https://www.futuremarketinsights.com/reports/sample/rep-gb-18931 The industry's growing emphasis on timely detection and avoidance of neurological illnesses is redefining business approaches in the brain monitoring sector. Businesses prioritizing research and...
PR Newswire
06/02/2024

icotec Medical Appoints Christoph Eigenmann as New US CEO and Promotes Carter…

Carter Lonsberry who led icotec US successfully in the first couple years, is appointed to become the US executive Chairman of the Board. His promotion is a testament to his invaluable contributions to the company's future in the US. In his new role, Carter Lonsberry will continue to shape the strategic initiatives. Carter Lonsberrywho led icotec US successfully in the first couple years, is appointed to become the US executive Chairman of the Board. His promotion is a testament to his...
PR Newswire
06/02/2024

Steel Wire Market Size to Grow USD 180.9 Billion by 2032 at a CAGR of 6.5% |…

The Global Steel Wire Market was valued at USD 96.6 Billion in 2022, and is projected to reach USD 180.9 Billion by 2032, growing at a CAGR of 6.5% from 2023 to 2032. The Global Steel Wire Market was valued atUSD 96.6 Billionin 2022, and is projected to reachUSD 180.9 Billionby 2032, growing at a CAGR of 6.5% from 2023 to 2032. Claim Your Free Sample Now:https://reports.valuates.com/request/sample/ALLI-Manu-1V80/Steel_Wire_Market Major Factors Driving the Growth of Steel...
PR Newswire
06/02/2024

Ipsen - Monthly information relative to the total number of voting rights and…

Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1)31 January 202483,814,526Gross...
Nasdaq GlobeNewswire
06/02/2024

Crossject provides strategic update on priorities for 2024

Focusing on regulatory filings and accelerating U.S. commercialization effortsContract of up to $155 million with BARDA for U.S. stockpiling continues to advance Dijon, France February 6, 2024 –530 pm CET Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free auto-injectors for emergency situations,provides a summary of recent milestones reached and an update on its strategic priorities for 2024.In January 2024, Crossject engaged Syneos...
Nasdaq GlobeNewswire
06/02/2024

Home Healthcare Market Worth $383.0 Billion | MarketsandMarkets™.

Browse in-depth TOC on "Home Healthcare Market" Browse in-depth TOC on "Home Healthcare Market" 288 - Tables 46 - Figures 352 - Pages Home Healthcare Market Scope: The therapeutic products segment accounted for the largest share of the home healthcare market, by product segment, in 2022 The home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. In 2022, the home healthcare market will...
PR Newswire
06/02/2024

Future Market Insights Predicts Robust Growth for Fertility Test Market, CAGR of…

Request Exclusive Sample Report: Fertility Test Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18940 Request Exclusive Sample Report: Fertility Test Industry Strategic Insights,https://www.futuremarketinsights.com/reports/sample/rep-gb-18940 In addition to rising infertility rates, there has been growing awareness about fertility testing options. More people are becoming educated on the importance of fertility testing and the benefits it can...
PR Newswire
06/02/2024

Virbac : Declaration of the number of shares and voting rights 01/2024

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsJanuary, 31 20248 458 000Gross total of voting rights :...
Nasdaq GlobeNewswire
06/02/2024

Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to…

The Company believes that the Flaskworks system will play a central role in enabling the efficient and timely scale-up of manufacturing to make DCVax-L products for large numbers of patients, and in reducing the manufacturing facility costs. The Company further believes that these efficiencies will be pivotal for enabling the DCVax-L platform to be affordable and potentially suitable for widespread use as a frontline therapy. The Company believes that the Flaskworks system will play a central...
PR Newswire
06/02/2024

Oxford-Harrington Rare Disease Centre Opens Call for Proposals

The OHC's 2024 Rare Disease Scholar Award seeks novel approaches to treat rare diseases, with a focus on neurological disorders, developmental and metabolic disorders, and rare cancers. Applications directed to other rare, genetic indications with a high unmet need are also of interest. Any therapeutic modality will be considered. Intellectual property rights are retained by the award recipient or their institution. The OHC's 2024 Rare Disease Scholar Award seeks novel approaches to treat…
PR Newswire
06/02/2024

Philips Sounds transform the sound of care, reducing patient monitoring alarm…

FDA 510(k) clearance of latest Philips IntelliVue patient monitor software helps drive alarm management strategies toward a more peaceful, healing environment for patients and caregiversAmsterdam, the Netherlands –Advances in healthcare technology continue to drive patient monitoring technology into the future; however, alarm sounds have remained similar, if not unchanged, for many years. Until now. Royal Philips (NYSE: PHG, AEX: PHIA), has received 510(k) clearance for its latest...
Nasdaq GlobeNewswire
06/02/2024

Linnea SA of Switzerland and Universidade Estadual de Campinas (Unicamp) Brazil…

The cannabinoid market in Latin America has been growing over the last years as a result of patients' demand for safe, reliable and effective therapy. The current cannabinoid delivery forms are often not aligned with the standards of quality typical of the pharmaceutical world and necessary to ensure the safety and the efficacy for patients.As the demand for cannabinoid therapies rises, health authorities are gradually creating rules to protect consumers and help healthcare personnel to...
Nasdaq GlobeNewswire
06/02/2024

GRANT OF PERFORMANCE SHARE UNITS

Pursuant to Ambu A/S' (Ambu) Remuneration Policy, a total of 172,956 Performance Share Units (PSUs) related to Ambu's long-term incentive programme (LTIP) for 2023/24 have been granted on 6 February 2024 with retroactive effect from 1 January 2024. 49,109 of the PSUs have been granted to the Executive Management and 123,847 of the PSUs have been granted to other key employees. The LTIP covers the financial year 2023/24, and the final allocation of PSUs is conditional upon achievement of two...
Nasdaq GlobeNewswire
06/02/2024

Evaxion Announces Closing of $15 Million Public Offering

/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing on February 5, 2024 of its previously announced public offering of 3,750,000 of its American Depositary Shares (“ADSs”) (or pre-funded warrants in lieu thereof) and warrants to purchase up to 3,750,000 ADSs at a combined public offering price of $4.00 per ADS (or pre-funded warrant in lieu thereof) and accompanying warrant...
Nasdaq GlobeNewswire
06/02/2024

AvenCell Announces First Patient Dosed in a Phase IA Study with lead product…

"Patients with AML with minimal residual disease or who progress after currently available treatment approaches generally have a very poor prognosis and limited options," said Professor Martin Wermke, Head of the Early Clinical Trial Unit at the National Cancer Center Dresden, Germany. "AvenCell's autologous switchable CAR-T therapy has already yielded highly promising early clinical results in AML treatment. AVC-201, a readily available donor-derived allogeneic cell product is…
PR Newswire
06/02/2024

Avalere Health Appoints New President of Medical To Lead a Tech-Enabled Future…

The appointment of Baoutis is the latest of several high-profile executive leadership announcements made following Avalere Health's rebrand on October 18, 2023, each reflecting Avalere Health's evolution as a connected organization. The rebrand saw the company bring together 1,500+ team members across 19 locations in North America, Europe and Asia, uniting them under a single vision, organization and brand. The appointment of Baoutis is the latest of several high-profile executive…
PR Newswire
06/02/2024

VISIBLE ALPHA LAUNCHES NEW BIOPHARMA PLATFORM

The pharmaceutical and biotech industries deliver constant innovation and are rapidly evolving. The demand for accurate and holistic drug-level forecasts is more important than ever before. This demand is amplified by evolving regulations, diverse clinical trial outcomes and frequent market fluctuations. The pharmaceutical and biotech industries deliver constant innovation and are rapidly evolving. The demand for accurate and holistic drug-level forecasts is more important than ever before...
PR Newswire
06/02/2024

The American National Red Cross Teams Up With Velico Medical In The Blood Center…

"This collaboration reflects the shared vision of Velico and the Red Cross of advancing life-saving blood products with the goal of improving patient care in the United States and around the world," says Richard Meehan, President, and CEO of Velico. "This collaboration reflects the shared vision of Velico and the Red Cross of advancing life-saving blood products with the goal of improving patient care inthe United Statesand around the world," saysRichard Meehan, President…
PR Newswire
06/02/2024

NICE Endorses Brainomix AI-Enabled Software in Stroke

The NICE guidance elevates the Brainomix 360 stroke platform, the European market leading solution now entering the US market, to an evidence generation framework, which enables stroke units across the UK to utilize the technology while further evidence is collected. The NICE guidance elevates the Brainomix 360 stroke platform, the European market leading solution now entering the US market, to an evidence generation framework, which enables stroke units across the UK to utilize the…
PR Newswire
06/02/2024

Essity on CDP's prestigious A List for sustainability

With its ambitious efforts to prevent deforestation and promote responsible forestry, Essity is a leader in terms of its objectives, actions, and transparency in the environmental field. One of the ways Essity works to combat deforestation is through the Consumer Goods Forum and its Forest Positive Coalition of Action, in which Essity, together with other companies and organizations, systematically addresses deforestation and forest destruction and promotes biodiversity. With its ambitious...
PR Newswire
06/02/2024

Novo Holdings invests in Manipal Hospitals, a leading private hospital chain in…

A rising middle class, paired with an increased appreciation for advanced medical facilities and quality healthcare services, has driven an uptick in demand for private hospital care in the country. Other factors include the expansion of health insurance coverage and the sophistication of medical technology adopted at private institutions.Dr. Amit Kakar, Managing Partner and Head of Novo Holdings Asia Investments, said"The demand for affordable and accessible private healthcare services in…
PR Newswire
06/02/2024

Digital Health Progress Report: IDTechEx Examines the Future of Healthcare…

IDTechEx have recently launched the report "Digital Health and Artificial Intelligence 2024-2034: Trends, Opportunities, and Outlook", covering the status of the digital health market with a focus on healthcare delivery. Topics covered in the report include telehealth, remote patient monitoring (RPM), consumer health wearables, digital health apps, and image recognition artificial intelligence for medical diagnosis. The report provides an overview of the technologies and trends that…
PR Newswire
06/02/2024

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 6 February 2024– The execution of Novo Nordisk A/S' overall share repurchase programme for 2024 of DKK 20 billion will be initiated on 6 February 2024. As part of this, Novo Nordisk A/S has now initiated a new share repurchase programme of up to DKK 2.1 billion in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour…
Nasdaq GlobeNewswire
06/02/2024
Altri  Comunicati